CRISPR/Cas9-Mediated Targeted Mutagenesis of CYP93E2 Modulates the Triterpene Saponin Biosynthesis in Medicago truncatula by Confalonieri, M. et al.
ORIGINAL RESEARCH
published: 26 July 2021
doi: 10.3389/fpls.2021.690231













This article was submitted to
Plant Metabolism and Chemodiversity,
a section of the journal
Frontiers in Plant Science
Received: 02 April 2021
Accepted: 29 June 2021
Published: 26 July 2021
Citation:
Confalonieri M, Carelli M, Gianoglio S,
Moglia A, Biazzi E and Tava A (2021)
CRISPR/Cas9-Mediated Targeted
Mutagenesis of CYP93E2 Modulates
the Triterpene Saponin Biosynthesis in
Medicago truncatula.
Front. Plant Sci. 12:690231.
doi: 10.3389/fpls.2021.690231
CRISPR/Cas9-Mediated Targeted
Mutagenesis of CYP93E2 Modulates
the Triterpene Saponin Biosynthesis
in Medicago truncatula
Massimo Confalonieri 1*, Maria Carelli 1, Silvia Gianoglio 2,3, Andrea Moglia 2, Elisa Biazzi 1
and Aldo Tava 1
1Council for Agricultural Research and Economics, Research Centre for Animal Production and Aquaculture, Lodi, Italy,
2Department of Agricultural, Forest and Food Sciences, Plant Genetics and Breeding, University of Torino, Grugliasco, Italy,
3 Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones Científicas, Universidad
Politécnica de Valencia, Valencia, Spain
In the Medicago genus, triterpene saponins are a group of bioactive compounds
extensively studied for their different biological and pharmaceutical properties. In this
work, the CRISPR/Cas9-based approach with two single-site guide RNAs was used in
Medicago truncatula (barrel medic) to knock-out the CYP93E2 and CYP72A61 genes,
which are responsible for the biosynthesis of soyasapogenol B, the most abundant
soyasapogenol in Medicago spp. No transgenic plants carrying mutations in the target
CYP72A61 gene were recovered while fifty-two putative CYP93E2 mutant plant lines
were obtained following Agrobacterium tumefaciens-mediated transformation. Among
these, the fifty-one sequenced plant lines give an editing efficiency of 84%. Sequencing
revealed that these lines had various mutation patterns at the target sites. Four T0 mutant
plant lines were further selected and examined for their sapogenin content and plant
growth performance under greenhouse conditions. The results showed that all tested
CYP93E2 knock-out mutants did not produce soyasapogenols in the leaves, stems
and roots, and diverted the metabolic flux toward the production of valuable hemolytic
sapogenins. No adverse influence was observed on the plant morphological features
of CYP93E2mutants under greenhouse conditions. In addition, differential expression of
saponin pathway genes was observed inCYP93E2mutants in comparison to the control.
Our results provide new and interesting insights into the application of CRISPR/Cas9
for metabolic engineering of high-value compounds of plant origin and will be useful to
investigate the physiological functions of saponins in planta.
Keywords: Medicago truncatula, triterpene saponin, CRISPR/Cas9, secondary metabolism, genome editing,
cytochrome P450
INTRODUCTION
Saponins are a large group of triterpene or steroid glycosides common to many plant species
(Haralampidisis et al., 2002) exhibiting a wide spectrum of biological and pharmacological
activities (Sparg et al., 2004; Tava and Avato, 2006; Augustin et al., 2011; Moses et al., 2014a).
These properties have, in the last decades, stimulated research on triterpene saponin biosynthetic
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pathways using Medicago truncatula (barrel medic) as model
plant species (Carelli et al., 2020). In the Medicago genus,
saponins are a complex mixture of olean-type glycosides
with medicagenic acid, zanhic acid, hederagenin, bayogenin
and soyasapogenols A and B as aglycones (Tava and Avato,
2006). All the saponins from Medicago spp. possess the
triterpenic pentacyclic nucleus belonging to the class of β-
amyrin (Tava et al., 2011). Subsequent modifications in specific
positions of the basic β-amyrin backbone by oxidative reactions
mediated by different cytochrome P450 (CYP450s) oxygenases
lead to distinct sapogenins (Tava et al., 2011) (Figure 1).
The sapogenins are then subjected to glycosylation reactions
mediated by glycosyltransferases to give the different saponins
(Augustin et al., 2011). Based on the position and the
oxidation degree of their functional groups, it is possible to
distinguish two different classes of sapogenins in Medicago
spp.: soyasapogenols are characterized by a hydroxyl group at
the C-24 position and are defined non-hemolytic sapogenins
while hemolytic sapogenins have a hydroxyl or carboxyl
group at C-23 and a carboxyl group at C-28 (Tava et al.,
2011) (Figure 1). The hemolytic and non-hemolytic sapogenins
are synthesized through independent biosynthetic pathways,
and have different chemical structures, biological activity and
distribution in plant organs (Tava et al., 2011; Carelli et al.,
2020). In particular, hemolytic sapogenins such as bayogenin,
hederagenin, medicagenic acid, zanhic acid and their glycosides,
which represent the most abundant saponins in the Medicago
genus, showed significant biological and pharmacological
properties, including fungistatic, insecticidal, antimicrobial,
antifeeding, apoptotic, nematocidal, anthelmintic, cytotoxic,
hypocholesterolemic, antiatherosclerotic, neuroprotective and
anticarcinogenic activities (Avato et al., 2006, 2017; Tava and
Avato, 2006; Argentieri et al., 2008; Balestrazzi et al., 2011;
Rafińska et al., 2017; Maestrini et al., 2019, 2020; D’Addabbo
et al., 2020). On the other hand, the soyasapogenol saponins
are lacking of hemolytic characteristics and for this reason
they have a low biological and pharmacological activity (Tava
and Avato, 2006; Argentieri et al., 2008; Rafińska et al., 2017;
Carelli et al., 2020). Due to their properties, hemolytic saponins
from Medicago spp. are valuable specialized metabolites to
be employed in the agro-industry and for pharmaceutical
applications (Ellen et al., 2007; Bora and Sharma, 2011; Rafińska
et al., 2017).
In M. truncatula, almost all of the P450s that are involved in
the hemolytic sapogenin biosynthesis have been identified and
their functional role has been characterized (Carelli et al., 2011;
Fukushima et al., 2011, 2013; Biazzi et al., 2015; Ribeiro et al.,
2020). However, the in planta function of a limited number of
these P450s was determined. To date, two CYP450s key genes
have been identified in the non-hemolytic sapogenin pathway
in M. truncatula, and their role has been characterized only in
vitro using a yeast heterologous expression system: CYP93E2
catalyzes the C-24 hydroxylation of β-amyrin (Fukushima et al.,
2011), after which CYP72A61 catalyzes the hydroxylation of
24-hydroxy-β-amyrin at C-22-β position (Fukushima et al.,
2013) resulting in the biosynthesis of soyasapogenol B, the most
abundant soyasapogenol in the genusMedicago.
Mutants are pivotal for understanding gene function and to
elucidate metabolic pathways and can be a valuable resource
for crop improvement as well (Liu et al., 2018). Mutant
legume plants with modified sapogenin composition have been
described. By combining an activation tagging method and
a reverse genetic TILLING approach, Carelli et al. (2011)
identified M. truncatula plant lines mutated in CYP716A12, a
key gene in hemolytic sapogenin biosynthesis. These mutants
were unable to produce hemolytic sapogenins, synthesized only
soyasaponins and showed severe phenotypic effects such as
reduced plant growth and seed germination delay. In addition,
another M. truncatula mutant line carrying a loss-of-function
allele in CYP72A67 was discovered in the same TILLING
collection. CYP72A67 mutant plants showed altered hemolytic
sapogenin production without significant effects on plant growth
and reproduction (Biazzi et al., 2015). Krishnamurthy et al.
(2019), using a high-density soybean mutant library, isolated
GmBas1, CYP93E1, and CYP72A61 mutants. In particular,
they showed that CYP93E1 mutants were deficient in total
saponins and accumulated a novel saponin having sophoradiol
as aglycone. Suzuki et al. (2019) assessed in Lotus japonicus the
in planta roles of two P450s (LjCYP93E1 and CYP716A51) in
triterpenoid biosynthesis by performing gene loss-of-function
studies, and showed that LjCYP93E1 homozygous mutant plants
did not accumulate soyasapogenols. However, at present no
mutant plant lines lacking non-hemolytic sapogenins have been
reported and characterized in Medicago spp. Moreover, their
specific physiological role in plant growth and development is
still unexplored.
Innovative genetic engineering methods have been recently
developed to modify specific sites in targeted genes and generate
knock-out mutants (Sedeek et al., 2019; Confalonieri and
Sparvoli, 2020). Of these, the CRISPR (Clustered Regularly
Interspaced Short Palindromic Repeats)/Cas9 system due to
its high efficiency, simplicity and specificity has become a
powerful and effective tool for targeted genome editing and
research into gene function in plants (Doudna and Charpentier,
2014; Manghwar et al., 2019). This technology makes it
possible to induce point mutations in one or some target
sequences simultaneously, as well as to introduce new genetic
variants by homology directed recombination (HDR) or to
target and modify transcription. At present, few studies have
been published related to the CRISPR/Cas9-mediated genome
editing on Medicago spp. (Michno et al., 2015; Curtin et al.,
2017, 2018; Meng et al., 2017; Gao et al., 2018; Wang
et al., 2018; Yu et al., 2018; Wolabu et al., 2020), but
none of them involved specific genes associated with the
saponin metabolism.
In this study, we used the CRISPR/Cas9 technology in the
model legume Medicago truncatula to knock-out CYP93E2 and
CYP72A61, the two key genes of the non-hemolytic sapogenin
pathway, in order to elucidate their specific roles in saponin
biosynthesis in planta and explore their possible involvement
in plant growth and development. A number of new allelic
CYP93E2 variants were obtained while no CYP72A61 mutants
were produced. Selected CYP93E2 mutant lines were analyzed
for sapogenin content and plant growth performances. The
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FIGURE 1 | Biosynthetic pathway of triterpene sapogenins in Medicago truncatula.
present work illustrates the feasibility of using CRISPR/Cas9-
targeted mutagenesis to knock-out CYP93E2 in M. truncatula.
We demonstrated for the first time the success of this strategy to
block the metabolic flux to non-hemolytic saponins, highlighting
the potential for converting β-amyrin to hemolytic saponins.
MATERIALS AND METHODS
Plant Material and Growth Conditions
The Medicago truncatula cultivar Jemalong (M9-10a genotype)
was used for tissue culture and transformation. This genotype
was selected by Neves (2000) for its high regeneration potential
via somatic embryogenesis. M9-10a plantlets were grown and
micropropagated in vitro as described by Faè et al. (2014). In
vitro cultures were kept in a growth chamber at 22–24◦C with
16 h photoperiod of 65–75 µmol m−2 s−1 under cool white
fluorescent lamp.
SgRNA Design and CRISPR/Cas9 Vector
Construction
gRNA sequences were selected using the CRISPR-P webtool
(http://crispr.hzau.edu.cn/CRISPR2/), taking into account gRNA
position and their on-target scores, using theMedicago truncatula
Mt40v2 genome as reference. Putative off-target loci were
further evaluated with Cas-OFFinder (http://www.rgenome.
net/cas-offinder/) using the same reference genome, looking
for up to five mismatches. Vector assembly was carried
out according to the GoldenBraid cloning standard (https://
gbcloning.upv.es/). The GB parts used in the assembly are listed
in Supplementary Table 1. The final pCambia pDGB3 omega1
vectors, pDGB3 omega1 nptII-gRNA1-gRNA2-Cas9 (CYP93E2)
and pDGB3 omega1 nptII-gRNA1-gRNA2-Cas9 (CYP72A61),
were transformed in EHA105 A. tumefaciens electrocompetent
cells. As a negative control pDGB3 omega1 nptII-Cas9 vector
was used.
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Plant Transformation and Generation of
Transgenic Barrel Medic Lines
The Agrobacterium tumefaciens-mediated transformation
procedure of M9-10a leaf explants was based on the protocol
described by Confalonieri et al. (2009). Briefly, wounded leaflets
were dipped into the EHA105 Agrobacterium suspension
(OD600 = 1.6) and then co-cultivated for 5 days on solid
embryo induction medium (EIM) in the dark. Subsequently,
the inoculated explants were transferred on the same medium
supplemented with carbenicillin (500 mg/L) and kanamycin
(100 mg/L). After 3 weeks, leaf explants with embryogenic
calli were transferred and subcultured on embryo proliferation
medium (EPM) with the same antibiotic concentrations, until
somatic embryos could be isolated. The kanamycin-resistant
embryos were then grown on selective Embryo Conversion
Medium (ECM) to develop into plantlets. Before acclimation
and transplanting into pots to the greenhouse, putative mutant
and control transgenic plants were subjected to antibiotic
screening and surviving shoots were transferred to root-inducing
medium for regeneration of complete plants.
Screening for Mutations Induced by
CRISPR/Cas9 in CYP93E2 Gene
Genomic DNA was extracted from leaves of analyzed plants
using a genomic DNA extraction kit (Sigma-Aldrich) following
the manufacturer’s protocols. The genomic DNA was used as
template in a PCR amplification reaction using primers that
were designed to amplify the CAS9 gene and 600 and 650
bp amplicons containing the specific sg1RNA and sg2RNA
target sequences, respectively (Supplementary Table 2). PCR
products were treated with Exonuclease I and FastAp thermo-
sensitive alkaline phosphatase, purified by precipitation with
ethanol:EDTA and sequenced using the Mycrosynth Barcodes
Easy run service (Microsynth SeqLabDE - 37081 Göttingen).
Sequences were analyzed using the TIDE web tool (https://
tide.nki.nl/ Brinkman et al., 2014) in order to evaluate editing
efficiency at the target sites as well as pattern of mutations.
Greenhouse Evaluation of CYP93E2Mutant
Lines
To evaluate the effects of CRISPR/Cas9 editing of CYP93E2
on plant growth features and sapogenin content, the well-
rooted in vitro CYP93E2 mutant and control transgenic plants
(T0 generation) were transplanted into pots (12 cm diameter)
containing a mixture of peat and soil (1:2) and acclimatized for a
week under growth chamber conditions (16 h of light at 24◦C and
8 h of dark at 22◦C), until shoot growth started. Subsequently,
they were transferred in greenhouse at the beginning of the
growing season at a temperature of 20–24◦C, with a natural
photoperiod. All the agronomic techniques were performed
following the standard trial procedures. A total of 20 transgenic
plants were analyzed, corresponding to 4 biological replicates of
four independent CYP93E2 mutants (T81 8, T83 1, T83 8, and
T83 14) and a control transgenic line. The experimental design
of the greenhouse experiment was a randomized complete block
design with four replications of single-plant experimental units.
Leaf, stem and root samples were collected from start flowering
plants. The following parameters were evaluated: number of days
from transplanting to flowering, fresh and dry weight of leaf, stem
and root biomass. For dry weight measure, fresh samples were
frozen at−80◦C and then lyophilized.
Analysis of the Sapogenin Content in the
Plant Material
Leaves, stems and roots were separately harvested from each
plant grown in a greenhouse and independently analyzed. Four
replicated plants from all CYP93E2 mutant lines and a control
line were used for biochemical determination. Immediately
after sampling, fresh plant tissues were frozen at −80◦C and
then lyophilized. All the aglycone moieties were considered as
representative of the corresponding glycosides and evaluated
by chemical methods. Sapogenins were obtained after acid
hydrolyses of the corresponding saponins, as reported by Tava
et al. (2020), identified by GC/MS and quantitated by GC/FID
as their methyl/silyl derivatives considering all the obtained
artifacts (Tava et al., 2017) (Supplementary Figure 1). Hundred
milligram of plant material were treated with 50ml of 2M
HCl in 50% aqueous methanol under reflux for 8 h. Uvaol
(0.2mg) was added as internal standard, methanol was removed
in vacuo and the aglycones were extracted with ethyl acetate
(3 × 20ml). The organic solution was dried under anhydrous
Na2SO4 and evaporated to dryness. Aglycones were dissolved
in 0.5mL of MeOH, treated with CH2N2 for 15min and then
the solvent eliminated under a stream of N2. Silylation was
performed on the methylated sapogenins using 0.2mL of a
mixture of pyridine-hexamethyldisilazane-chlorotrimethylsilane
(Merck) 2:1:1 at 70◦C for 10min. Samples were diluted with
isooctane and used for GC/FID and GC/MS analyses. GC/FID
analyses were performed with a 30m × 0.32mm, 0.25µm i.d.,
DB-5 capillary column. Injector and detector temperatures were
set at 350◦C; the oven temperature program was: 90◦C for 5min,
increased at 20◦C/min to 250◦C for 1min and then increased at
4◦C/min to 350◦C for 15min. Samples (1 µL) were injected in
the “splitless” mode. He was the carrier gas with a head pressure
of 12.2 psi. GC/MS analyses were carried out using a 30m ×
0.25mm, 0.25µm i.d., Elite-5MS capillary column using the
same chromatographic conditions as for GC/FID. Mass spectra
were acquired over 50–850 amu range at 1 scan/s with ionizing
electron energy 70 eV. Transfer line 300◦C, carrier gas He at 1.2
mL/min. Retention times andMS spectra were compared to those
of previously identified sapogenins, considering all the formed
artifact compounds as reported in Tava et al. (2017). All samples
were analyzed in triplicate.
Expression Analysis of Saponin Metabolic
Pathway-Related Genes in CYP93E2
Mutant Lines
Expression analysis of saponin pathway-related genes was
performed by quantitative real-time PCR. CYP93E2, CYP72A61,
CYP716A12,CYP72A67,CYP72A68,CYP88A13, and BAS1 genes
were analyzed. Total RNA was extracted from fully developed
trifoliate leaves and roots of mutant and control plants harvested
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at the beginning of flowering, using the Nucleospin RNA
plant kit (Macherey-Nagel, Düren, Germany) according to the
manufacturer’s protocol. For each transgenic line, four plants
(biological replicates) were analyzed. cDNA was synthesized
using the iScript cDNA Synthesis Kit (Bio-Rad) starting from
1 µg of RNA. cDNA was diluted 1:5 and 3 µl was used as a
template in a 10 µl reaction containing 5 µl of SSoFast EvaGreen
supermix (Bio-Rad) and specific primers for the selected genes
(Supplementary Table 2). Thermal cycling conditions were:
3min of initial denaturation at 95◦C, 50 cycles of denaturation
(95◦C; 25 s), annealing and extension (59.5◦C; 3 s) and a final
melting analysis from 55 to 95◦Cwith a 1◦C increase at each step.
The Medicago sativa translationally controlled tumor protein
Msc27 (Pay et al., 1992) and Actin control genes were amplified
in the same conditions. qRT-PCR reactions and analyses were
carried out on three replicates each in a Rotor Gene 6000
(Qiagen) as previously described (Carelli et al., 2015). The gene
expression levels were calculated by the comparative Ct method
using the equation E = 2−11Ct. 11Ct values were calculated as
differences in 1Ct between edited lines (leaves or roots) and the
roots of control line.
Statistical Analysis
All data were subjected to the Analysis of Variance (ANOVA).
Mean comparison between control and CYP93E2 mutant lines
was done by Dunnett’s Test (p < 0.05) (SAS Proc GLM, SAS
Institute Inc., Cary, NC).
RESULTS
CRISPR/Cas9 Design to Knock-Out
CYP93E2 and CYP72A61 Genes in Barrel
Medic
For each of the target genes, two specific gRNAs were designed,
directed at their coding sequences. For each gene, one gRNA
was directed at the C-terminal Heme Cys domain, while the
other was chosen to be as close as possible to the 5’ end of
the coding sequence, in order to ensure the early disruption
of translation. The selected gRNAs also did not pose any
significant risk of off-target activity, as inferred by the in silico
prediction of putative off-target loci in theM. truncatula genome
(Supplementary Data 1). Each gRNA was put under the control
of the Arabidopsis U6-26 promoter. For each target gene, the
two gRNAs were assembled in a pCambia vector together
with the Cas9 endonuclease and the nptII selection marker for
kanamycin resistance.
Production of CYP93E2 Mutant Barrel
Medic Lines
Medicago truncatula was transformed using the EHA105A.
tumefaciens strain harboring the CRISPR/Cas9 binary vectors
targeting the CYP93E2 or the CYP72A61 genes. After several
weeks on selective embryo inducing and proliferating media
no somatic embryos were isolated from leaf explants co-
cultivated with EHA105 carrying the CYP72A61 targeting
construct. Differently, somatic embryos were produced from
embryogenic calli obtained from explants transformed with
the CYP93E2 targeting construct (Supplementary Figure 2;
Supplementary Table 3). Fifty-two putative CYP93E2 mutant
plant lines were recovered with a transformation efficiency of
6.4%. Fourteen kanamycin-resistant plant lines transformed with
the Cas9 and nptII genes without the gRNAs (control) were
also regenerated, with a comparable transformation efficiency
(4.4%). The genome-edited and control plant lines were found
to be phenotypically similar with no visible growth abnormalities
during in vitromicropropagation and acclimation to soil.
CRISPR/Cas9 Induces Highly Efficient
Mutagenesis of the CYP93E2 Gene
To determine whether the target CYP93E2 gene was mutated,
we genotyped 51 independent putative CYP93E2 mutants and
three control T0 plant lines using specific primers for the Cas9
gene and for regions flanking the CYP93E2 target sequences
(Supplementary Table 2; Figure 2A). All the 51 mutants and
the three control plant lines showed the genomic integration
of the transgene. Sequencing and chromatogram decomposition
analysis showed that, compared with the wild type sequence,
43 out of the 51 mutant plant lines (84.3%) carried mutations
in at least one of the two targeted sites of the CYP93E2 gene
(Supplementary Table 4). Considering gRNA1, all the 43 edited
lines showed target sequence mutations. Among these, 21 lines
were completely edited showing a homozygous mutation or
biallelic profiles. The other 22 lines had a partially edited
genotype (heterozygous) and retained a proportion of the wild
type allele (Supplementary Table 4). At the gRNA2 target locus,
a lower editing efficiency was observed as 25 of the 43 edited
plant lines retained the wild type sequence. In 11 lines a partially
edited genotype (heterozygous) was found and only seven lines
were completely edited showing a homozygous mutation or
biallelic profiles (Supplementary Table 4). The most frequent
types of mutation at the gRNA1 target site were a−4 bp deletion
and +T insertion (Figure 2B), while at the gRNA2 target site
32% of the observed mutations were long bp deletions. After
identifying the targeted mutations, we randomly selected four
(T81 8, T83 1, T83 8, and T83 14) T0 mutant lines based on
the different type mutations at the target sites of the CYP93E2
gene. Focusing on gRNA1, two were biallelic mutants and two
homozygous. Focusing on gRNA2, two were biallelic mutants,
one heterozygous and one wild type. The edited sequences of the
selected plant lines are shown in Figure 2C. The deduced amino
acid sequences of the CYP93E2 protein for the selected lines show
frame-shifting with the introduction of amino acid mutations in
the catalytic site and stop codons responsible for the premature
termination of protein translation (T81 8, T83 8) or the loss of
the ATG starting codon (T83 1, T83 14).
Phenotypic and Morphological
Observations of CYP93E2 Mutant Barrel
Medic Lines
CYP93E2 mutant and control plant lines showed similar
morphological features, flowered and produced seeds under
controlled environmental conditions. All tested plants showed
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FIGURE 2 | CRISPR/Cas9-editing in Medicago truncatula. (A) Gene structure of CYP93E2 with target sites of CRISPR/Cas9 gRNAs (blue arrows) designed in the first
and second exon. The red arrows represent primers used to screen mutations. (B) Rate of mutation sizes. Percentages were calculated by dividing the number of
events of each mutation size by the sum of total mutation events. (C) Representation of mutation events generated by the CRISPR/Cas9 system in CYP93E2 gene of
the four selected plant lines. Mutations were detected using as reference the control plant lines. The CYP93E2 target sequences are colored in blue. Within the
sequence alignment, deletions are represented by traits; insertions are shown with black bold letters. Mutation size and plant line ID are shown on the right. Guide
RNA (gRNA) and protospacer adjacent motif (PAM) are indicated in red and green, respectively.
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root nodulation with no visible differences between the control
and the CYP93E2 mutants. To investigate whether mutations
in the CYP93E2 gene affect the plant growth and yield, we
characterized the four selected T0 mutant lines by measuring
the number of days from transplanting to flowering and leaf,
stem and root biomass at the start of the flowering period.
All the tested mutants showed a similar flowering time than
the control (Figure 3A). Three mutant lines (T81 8, T83 1,
and T83 8) showed plant growth performances similar to the
control while the fourth mutant (T83 14) exhibited a significant
increase in plant biomass production, according to Dunnett’s test
(Figures 3B–D; Supplementary Figure 3). The results obtained
for the dry weight of shoot and root biomass confirmed the data
of the fresh weight measurements (Supplementary Figure 4).
Knock-Out of the CYP93E2 Gene by
CRISPR/Cas9 Affect Both Non-hemolytic
and Hemolytic Sapogenin Contents
To investigate the effects of knock-out mutations in the
CYP93E2 gene on the triterpene saponin content of leaves,
stems and roots, all selected mutant lines were biochemically
analyzed. All sapogenins were identified by using authentic
reference standards and quantitated considering all the obtained
sapogenins (Tava et al., 2017) (Supplementary Figure 1). The
results of this investigation are shown in Tables 1, 2 where the
amount (mg/g DM) of each identified sapogenin is reported
for aerial parts (leaves and stems) and roots, respectively. The
hemolytic sapogenin composition of all CYP93E2 mutant lines
is similar to the control, while no soyasapogenols have been
detected in any of the analyzed organs. The ANOVA revealed
significant differences (p < 0.0001) among the barrel medic
lines for the soyasapogenol B and A contents in the leaves,
stems and roots (Tables 1, 2). According to Dunnett’s test, all
mutant lines showed significant differences in the content of
both soyasapogenols compared to the control. Considering the
total content of hemolytic sapogenins in leaves, the ANOVA
revealed significant differences (p = 0.005) among the barrel
medic lines. Two (T81 8 and T83 8) mutant lines showed a
significantly higher total hemolytic sapogenin content, according
to Dunnett’s Test (Table 1; Figure 4). All mutant lines displayed
significant higher amounts of medicagenic acid when compared
to the control. Furthermore, three (T81 8, T83 1, and T83 8)
mutant lines showed significantly higher bayogenin level, and
two (T831 and T83 8) of them also displayed a significant
increase of zanhic acid content than the control (Table 1). The
amount ofmedicagenic acid and zanhic acid, themajor hemolytic
sapogenins in M. truncatula aerial parts, was more than two
times higher in T81 8 and T83 8 mutants compared to the
control. The total leaf sapogenin content varied in the range 2.47–
3.51 mg/g DM in CYP93E2 mutants and was not significantly
different from the control line (3.13 mg/g DM). According
to Dunnett’s Test, all mutant lines displayed significant higher
total amounts of hemolytic sapogenins in the stems when
compared to the control (Table 1; Figure 4). As seen in the
leaves, all tested lines showed significantly higher medicagenic
acid level, and the same two lines (T81 8 and T83 8) displayed
a significant increase of zanhic acid content than the control.
With regard to total sapogenin content in the stems, T83 8
displayed a similar level to the control, while the other three
mutant lines showed a significant reduction (Table 1). Differently
from the aerial part, in the roots the hemolytic sapogenins
oleanolic acid and 2β-hydroxy oleanolic acid were also detected
in both the control and edited lines (Table 2). The content of
all hemolytic sapogenins in roots, including oleanolic acid, 2β-
hydroxy oleanolic acid, hederagenin, bayogenin andmedicagenic
acid, was higher in all mutants than in the control. Specifically,
two (T81 8 and T83 8) mutant lines showed significantly higher
hederagenin content, and one (T83 8) of them also displayed a
significant increase of medicagenic acid content than the control,
according to Dunnett’s Test. No significant differences were
observed between CYP93E2 mutants and the control for the
total sapogenin content in roots. Interestingly, the biochemical
characterization revealed the presence of β-amyrin (0.08 mg/g
DM) in the roots of all mutant lines but not in the control,
and these differences were significant, according to Dunnett’s test
(Table 2).
Editing of CYP93E2 Affected Expression of
Genes Involved in the Saponin Pathway
Quantitative real-time PCR analysis was performed on leaves
and roots of the control and all the selected mutants for the
β-amyrin synthase BAS1 gene (Suzuki et al., 2002), for the
genes of the hemolytic sapogenin branch - CYP716A12 (Carelli
et al., 2011), CYP72A68 (Fukushima et al., 2013), CYP72A67
(Biazzi et al., 2015), CYP88A13 (Ribeiro et al., 2020) and for
the genes of the non-hemolytic sapogenin branch - CYP93E2
(Fukushima et al., 2011) and CYP72A61 (Fukushima et al., 2013).
The results are expressed as relative expression values using the
roots of the control line as reference. As regards the genes of
the hemolytic pathway, Dunnett’s Test revealed a significantly
enhanced accumulation of CYP72A67 and CYP72A68 transcripts
in the leaves of T83 1 mutant (Figure 5). Although ANOVA
revealed no significant differences (p = 0.08) in CYP716A12
expression in the leaves of barrel medic lines, higher expression
levels were detected for T83 1 and T83 14 mutants compared
to the control. Interestingly, CYP88A13, the gene responsible
for the synthesis of zanhic acid, was highly induced in leaves
of three (T81 8, T83 1, and T83 14) mutant lines. Zanhic acid
represent the last step of hemolytic saponin branch (Figure 1)
and together with medicagenic acid were the most abundant
sapogenins in leaves of CYP93E2 mutant lines (Table 1). The
up-regulation of genes involved in the hemolytic sapogenin
biosynthesis in some of the edited barrel medic lines was in
accordance with the increased levels of hemolytic sapogenins
found. As regards the genes of the non-hemolytic branch, two
(T831 and T83 14) mutant lines showed a higher amount of
CYP93E2 transcript in leaves, and one (T83 1) of them also
displayed a significant CYP72A61 up-regulation when compared
to the control (Figure 5). Concerning the BAS1 expression level
in leaves, the ANOVA revealed significant differences (p = 0.04)
among the tested lines and T83 1 showed a significant BAS1
up-regulation when compared to the control. No significant
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FIGURE 3 | Morphological observations of control and selected CYP93E2 mutant barrel medic plant lines under greenhouse conditions. (A) Number of days from
transplanting to flowering. (B–D) Leaf, stem and root fresh weight per plant at the start of plant flowering, respectively. The greenhouse experiment was performed
with four biological replications of single-plant experimental units. Data are shown as the mean values with error bars representing standard deviation. An asterisk
indicates means significantly different from control according to Dunnett’s Test (p < 0.05).
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TABLE 1 | Sapogenin content in aerial parts (leaves and stems) of control and CYP93E2 mutant barrel medic plant lines under greenhouse experimental conditions.
Plant organ Compound Plant line Statistics
Control T81 8 T83 1 T83 8 T83 14 F (df) Probability
Leaves Bayogenin 0.015 ± 0.002 0.034 ± 0.005* 0.032 ± 0.005* 0.047 ± 0.009* 0.028 ± 0.007 10.31 4 0.0007
Medicagenic acid 0.73 ± 0.14 1.58 ± 0.20* 1.45 ± 0.24* 1.85 ± 0.26* 1.28 ± 0.27* 10.06 4 0.0008
Zanhic acid 0.74 ± 0.22 1.52 ± 0.35* 1.00 ± 0.27 1.62 ± 0.27* 1.17 ± 0.35 4.56 4 0.018
Soyasapogenol A 0.07 ± 0.02 0.00* 0.00* 0.00* 0.00* 51.86 4 <0.0001
Soyasapogenol B 1.57 ± 0.45 0.00* 0.00* 0.00* 0.00* 44.80 4 <0.0001
Total hemolytic sapogenins 1.49 ± 0.36 3.14 ± 0.54* 2.49 ± 0.52 3.51 ± 0.54* 2.47 ± 0.62 6.53 4 0.005
Total non-hemolytic sapogenins 1.64 ± 0.47 0.00* 0.00* 0.00* 0.00* 45.16 4 <0.0001
Total sapogenins 3.13 ± 0.80 3.14 ± 0.54 2.49 ± 0.52 3.51 ± 0.54 2.47 ± 0.62 1.84 4 0.19
Stems Medicagenic acid 0.70 ± 0.05 1.08 ± 0.08* 1.38 ± 0.17* 1.74 ± 0.16* 1.20 ± 0.21* 19.52 4 <0.0001
Zanhic acid 0.06 ± 0.02 0.12 ± 0.03* 0.08 ± 0.02 0.20 ± 0.01* 0.10 ± 0.03 15.91 4 <0.0001
Soyasapogenol A 0.08 ± 0.01 0.00* 0.00* 0.00* 0.00* 260.4 4 < 0.0001
Soyasapogenol B 1.33 ± 0.31 0.00* 0.00* 0.00* 0.00* 67.61 4 <0.0001
Total hemolytic sapogenins 0.77 ± 0.07 1.20 ± 0.08* 1.46 ± 0.19* 1.95 ± 0.17* 1.30 ± 0.24* 20.30 4 <0.0001
Total non-hemolytic sapogenins 1.41 ± 0.32 0.00* 0.00* 0.00* 0.00* 73.41 4 <0.0001
Total sapogenins 2.17 ± 0.39 1.20 ± 0.08* 1.46 ± 0.19* 1.95 ± 0.17 1.30 ± 0.24* 11.57 4 0.0004
For each barrel medic line, data represent the mean values (mg/g DM) ± SD of four replicated plants. An asterisk indicates means significantly different from control according to
Dunnett’s test (p < 0.05).
TABLE 2 | Sapogenin content in roots of control and CYP93E2 mutant barrel medic plant lines under greenhouse experimental conditions.
Compound Plant line Statistics
Control T81 8 T83 1 T83 8 T83 14 F (df) Probability
β-amyrin nd 0.08 ± 0.02* 0.08 ± 0.03* 0.08 ± 0.01* 0.08 ± 0.01* 15.12 4 0.0001
2β-hydroxy oleanolic acid 0.20 ± 0.06 0.21 ± 0.04 0.24 ± 0.04 0.26 ± 0.03 0.25 ± 0.13 0.45 4 0.77
Oleanolic acid 0.26 ± 0.05 0.35 ± 0.05 0.36 ± 0.06 0.40 ± 0.06 0.36 ± 0.13 1.37 4 0.30
Hederagenin 0.66 ± 0.06 1.20 ± 0.25* 0.99 ± 0.20 1.30 ± 0.06* 1.10 ± 0.29 4.26 4 0.02
Bayogenin 0.60 ± 0.15 0.81 ± 0.19 0.85 ± 0.15 0.94 ± 0.08 0.85 ± 0.42 0.78 4 0.56
Medicagenic acid 1.31 ± 0.15 2.02 ± 0.46 1.90 ± 0.42 2.30 ± 0.25* 1.79 ± 0.51 2.46 4 0.10
Soyasapogenol A 0.01 ± 0.003 0.00* 0.00* 0.00* 0.00* 36.82 4 <0.0001
Soyasapogenol B 1.37 ± 0.27 0.00* 0.00* 0.00* 0.00* 92.47 4 <0.0001
Total hemolytic sapogenins 3.03 ± 0.46 4.58 ± 0.95 4.34 ± 0.82 5.20 ± 0.43 4.35 ± 1.47 2.02 4 0.15
Total non-hemolytic sapogenins 1.38 ± 0.28 0.00* 0.00* 0.00* 0.00* 91.77 4 <0.0001
Total sapogenins 4.40 ± 0.39 4.58 ± 0.95 4.34 ± 0.82 5.20 ± 0.43 4.35 ± 1.47 0.44 4 0.78
For each barrel medic line, data represent the mean values (mg/g DM) ± SD of four replicated plants. An asterisk indicates means significantly different from control according to
Dunnett’s test (p < 0.05).
differences in the expression profile of both hemolytic and non-
hemolytic genes in roots were observed among barrel medic
lines (Figure 5).
DISCUSSION
Metabolic engineering of triterpene saponin biosynthesis in
plants is a fascinating research topic from two main perspectives.
The wide potential use of saponins as biologically and
pharmacologically active compounds, and their possible effects
on fundamental plant developmental processes, make their
modulation an interesting tool for breeding and biotechnology.
Also, the development of plants with modified saponin profiles
could yield further understanding of their biosynthetic route
and regulation mechanisms. The metabolic engineering of both
the early and late stages of the saponin biosynthetic pathway
has been the topic of several reviews (Yendo et al., 2010;
Lambert et al., 2011; da Silva Magedans et al., 2020). The
major requirement for the successful engineering of specific
saponins is the knowledge of the genes/enzymes involved in their
biosynthesis. Over recent years, the economic relevance of these
valuable natural compounds led to a substantial understanding of
the biosynthetic routes of triterpene saponins, in particular inM.
truncatula, a rich source of different saponins and a model plant
species for legumes (Pateraki et al., 2015; Carelli et al., 2020).
Several members of P450 families have been characterized to be
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FIGURE 4 | Total hemolytic sapogenin content in leaves, stem and roots of control and CYP93E2 mutant barrel medic plants under greenhouse experimental
conditions. Data are shown as the mean values of four biological replications of single-plant experimental units with error bars representing standard deviation. An
asterisk indicates means significantly different from control according to Dunnett’s Test (p < 0.05).
involved in saponin biosynthesis of M. truncatula (Carelli et al.,
2011; Fukushima et al., 2011, 2013; Biazzi et al., 2015; Ribeiro
et al., 2020) but the in planta function of a limited number of
these P450s was determined. Furthermore, results from studies
with heterologous microbial systems do not always correspond
with in planta function. By using a yeast expression system, Biazzi
et al. (2015) supported the hypothesis that CYP72A68 is mainly
involved in the biosynthesis of medicagenic acid, while Tzin
et al. (2019) showed that CYP72A68 is a multi-functional oxidase
responsible for hederagenin, gypsogenin and gypsogenic acid
based on in vivo and in planta evidence. To date, the functional
roles in planta of CYP93E2 and CYP72A61, which participate in
the biosynthesis of non-hemolytic sapogenins in M. truncatula,
have not been demonstrated yet. The biochemical functions of
these P450 key enzymes and the physiological roles of saponins
in barrel medic could be elucidated by characterization of knock-
out mutants or gene over-expression. Few studies reported
the CRISPR/Cas9-mediated genome editing in Medicago spp.
(Michno et al., 2015; Curtin et al., 2017, 2018; Meng et al., 2017;
Gao et al., 2018; Wang et al., 2018; Yu et al., 2018; Wolabu et al.,
2020) and none of them involved specific genes associated with
the metabolism of saponins.
In this work, we used the CRISPR/Cas9 technology in
the model legume Medicago truncatula to knock-out two key
CYP450 genes of the non-hemolytic saponin pathway (CYP93E2
and CYP72A61), in order to demonstrate their specific role in
planta and explore their possible involvement in growth and
development. We adopted a dual gRNA approach for targeting
CYP93E2 and CYP72A61 in order to enhance the genome
editing efficiency by either increasing the probability of successful
mutagenesis, or even deleting large gene fragments (Nian et al.,
2017; Pauwels et al., 2018; Do et al., 2019), and we made use of
assembly of the GoldenBraid GB cloning system suited for gene
editing experiments (Vazquez-Vilar et al., 2016; Aliaga-Franco
et al., 2019; Maioli et al., 2020). In this study, we demonstrate
for the first time that CYP93E2 can be efficiently edited in
M. truncatula, resulting in the manipulation of the saponin
metabolic pathway. Heterozygous, biallelic and homozygous
mutants were detected in T0 plants, suggesting that editing
occurred at an early stage of the transformation/regeneration
processes (Li et al., 2018). The overall gene editing efficiency was
84%, higher than what observed in other published works in M.
truncatula (Meng et al., 2017; Curtin et al., 2018; Wolabu et al.,
2020). All the 43 edited lines showed mutations at the gRNA1
locus. The gRNA2 locus showed a lower mutation rate, with
25 of the 43 (58%) edited plant lines not showing any editing
effect (Supplementary Table 4). Although the editing efficiency
was different between the two gRNAs, it was not possible to
attribute this discrepancy to the different GC contents of the
target sequences or sgRNA secondary structure or promoters that
direct Cas9 and gRNAs expression (Ma et al., 2015). Interestingly,
the most frequent types of mutation at the CYP93E2 gRNA1
target site were a −4 bp deletion and the insertion of a single
nucleotide, while at the gRNA2 target site 32% of the observed
mutations were long bp deletions (Figure 2B). In M. truncatula
deletion of 1–10 nucleotides were the most common mutations
(Michno et al., 2015; Meng et al., 2017; Curtin et al., 2018). The
mutation pattern is consistent with that predicted with CRISPOR
(http://crispor.tefor.net/) based on microhomology. Off-target
mutations have not proven to be a cause for concern in plants
(Hahn and Nekrasov, 2019) contrary to what was observed in
human cells (Fu et al., 2013). The presence of mismatches in
the seed region between the selected sgRNA and the off-targets
supports the mutation efficiency (Hahn and Nekrasov, 2019),
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FIGURE 5 | Expression analysis using quantitative RT-PCR on sapogenin pathway genes. Values were calculated by the comparative Ct (cycle threshold) method
using roots of control line as reference. Values are means ± SE of four biological replicates. An asterisk indicates means significantly different from control according to
Dunnett’s Test (p < 0.05).
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since this 3’ terminal region of the target sequence strongly affects
recognition by Cas9. The prospective off-target activity with the
gRNAs used in this work was predicted using CasOFFinder,
and no loci were found in the M. truncatula genome which
could be considered as a likely source of off-target gene editing
(Supplementary Data 1). In the only 2 prospective off-target loci
with fewer than 3mismatches with respect to the gRNA sequence,
these were located in the seed region, and would therefore highly
impair recognition.
Among all CYP93E2 T0 mutant plant lines, four
representative lines were chosen for further phenotype
observation and biochemical analyses. The results of greenhouse
trial showed no significant differences between most of the tested
mutant lines (T81 8, T83 1 and T83 8) and the control in shoot
and root biomass (Figure 3). These plant lines exhibited normal
flowering time and produced seeds. These results were similar to
a previous report which showed that homozygous mutant lines
of Lotus japonicus harboring Lotus retrotrasposon1 (LORE1)
in LjCYP93E1, an orthologous of the M. truncatula CYP93E2,
did not accumulate soyasapogenols without significant effects
on plant growth and reproduction (Suzuki et al., 2019). The
same authors suggest that the soyasaponins are not necessary
for plant growth in Lotus japonicus. Biazzi et al. (2015) reported
that TILLING barrel medic mutants of CYP72A67, a key
enzyme in the biosynthesis of hemolytic sapogenins in M.
truncatula, accumulated gypsogenin, gypsogenic acid, and
16α-hydroxy gypsogenic acid instead of medicagenic and
zanhic acids in the leaves, without affecting plant growth
and reproduction. Krishnamurthy et al. (2019) reported the
modification of saponin composition in soybean mutants
isolated from a high-density soybean mutant library targeted
to β-amyrin synthase, and showed that mutant plants grow
normally. Furthermore, Confalonieri et al. (2009) showed
that the ectopic expression of a β-amyrin synthase-encoding
sequence (AsOXA1) in transgenic M. truncatula led to higher
accumulation of triterpene sapogenins and enhanced root
nodulation without significant effects on plant growth and
biomass. Unexpectedly, a fourth CYP93E2 mutant line (T83 14)
showed a significant enhancement of biomass production, and
exhibited flowering time and seed recovery similar to the control
and the other CYP93E2mutants (Figure 3). These specific results
differ from previous reports which revealed detrimental effects
on plant growth of M. truncatula associated to a mutation of
genes encoding P450s or UDP- glycosyltransferases involved in
hemolytic saponin biosynthesis (Naoumkina et al., 2010; Carelli
et al., 2011). The differences in plant growth performances
observed for T83 14 mutant line could result from positional
effects or somaclonal variation which are not unusual in
the production of transgenic plants and therefore cannot be
excluded. In conclusion, no adverse influence was observed on
the plant morphological features of CYP93E2 mutants under
greenhouse conditions.
To examine in detail the metabolic changes between the
control and CYP93E2 mutant barrel medic lines, we compared
the triterpenoid sapogenin composition of the leaves, stems and
roots. Our objective was to generate CYP93E2M. truncatula
knock-out mutants in which the metabolic flux to non-hemolytic
saponins is totally blocked, with a potential impact on valuable
hemolytic saponin levels. Gene editing tools allowed us to obtain
mutants with a homogeneous genetic background, without
stacking other mutations. As expected, all tested CYP93E2
mutants did not accumulate soyasapogenols in any aerial and
subterranean organs. These results provide the first in planta
demonstration of the key role of CYP93E2 in the control of
triterpenoid saponin accumulation, confirming the results of
yeast heterologous expression studies by Fukushima et al. (2011)
and Moses et al. (2014b), and are consistent with previous
findings reported for other legume species (Suzuki et al., 2019).
So, in Medicago truncatula CYP93E2 is directly involved in
soyasaponin biosynthesis by catalyzing the C-24 hydroxylation
of the β-amyrin backbone and its loss of function is sufficient
to completely suppress non-hemolytic sapogenin biosynthesis.
Sophoradiol, a β-amyrin derivative oxidized at the C-22 position
by the CYP72A61, was not detected in aerial and subterranean
organs of all CYP93E2 mutant and control lines. Differently,
Suzuki et al. (2019) showed accumulation of sophoradiol in
LyCYP93E1 Lotus japonicus mutants, and Krishnamurthy et al.
(2019) detected this compound in CYP93E1 soybean mutants.
In particular, Suzuki et al. (2019) proposed for L. japonicus
a triterpenoid biosynthetic pathway with two possible paths
starting from β-amyrin toward soyasapogenol B, one of which
is catalyzed by LjCYP93E1. Our results provide the evidence
that CYP93E2 is the first and only enzyme responsible for the
first key oxidative step of non-hemolytic saponin pathway in M.
truncatula. The differences between results from L. japonicus and
soybean and the ones observed in our study might be related to
the physiological differences between the legume species and to
the different plant organs (leaves, stems and roots vs. hypocotyls
and cotyledons).
Knocking-out CYP93E2 influenced the biosynthetic pathway
of hemolytic saponins and resulted in the redirection of
metabolic fluxes in all the tested mutant lines. In fact, the leaves
of allCYP93E2mutant lines accumulated higher amounts of total
hemolytic sapogenins than those of the control plants (Figure 4).
In T81 8 and T83 8 mutants, the plant lines with the significantly
higher total hemolytic sapogenin content, the amount of
medicagenic and zanhic acid, known as the major hemolytic
sapogenins in M. truncatula aerial parts (Kapusta et al., 2005;
Tava and Avato, 2006; Lei et al., 2019), was more than doubled
with respect to the control. Furthermore, the total leaf sapogenin
content of all CYP93E2 mutants was not significantly different
from the control line. In stems, despite the significant increase
in hemolytic sapogenins in all the tested mutants, most of them
did not totally compensate for the absence of soyasapogenols.
In roots, the content of hemolytic sapogenins was less variable
with only two mutants (T81 8 and T83 8) showing significantly
higher hederagenin content than the control, and T83 8 having a
significantly higher medicagenic acid content (Table 2). Overall,
these results indicate that the absence of soyasapogenols induced
a compensation by the increased accumulation of hemolytic
sapogenins (Figure 4). Suzuki et al. (2019) showed an increase
of oleanolic acid only in the roots of LyCYP93E1 mutant
plants, while our quantitative biochemical data clearly indicate
that the absence of soyasapogenols in the MtCYP93E2 mutants
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induced an increase in the accumulation of hemolytic sapogenins
in all tested organs. The plant response to the absence of
hemolytic sapogenins was not the same; in fact, Carelli et al.
(2011) demonstrated that knock-out mutants of CYP716A12,
a key enzyme catalyzing the first step of hemolytic sapogenin
pathway, blocked the synthesis of all hemolytic sapogenins
without significant and consistent effects on soyasapogenol
levels. Interestingly, the biochemical characterization revealed
the presence of β-amyrin in the roots of all mutant plant
lines, but not in the control. The significant accumulation
of β-amyrin, a common precursor of both hemolytic and
non-hemolytic sapogenins, could be the direct consequence
of the metabolic block toward soyasapogenol production
imposed on CYP93E2 mutants, and this result is consistent
with previous findings (Suzuki et al., 2019). Differently, β-
amyrin was not detected in the leaves and stems of CYP93E2
mutants, suggesting that this precursor is entirely converted to
hemolytic sapogenins.
To verify whether CYP93E2 mutations had caused changes
in gene expression, qRT-PCR was used to detect the expression
levels of genes related to hemolytic and non-hemolytic sapogenin
pathway. All the tested mutant lines partially or totally
compensate the absence of soyasapogenols by increasing the
content of hemolytic sapogenins in order to maintain a
total sapogenin “threshold” content similar to the control
(Tables 1, 2; Figure 4). Overall, the increased content of
hemolytic sapogenins was not directly correlated with the
expression of the corresponding genes, except for the T 83 1 and
T83 14 mutants. The reason of this discrepancy could be that
at the sampling time of analysis (start of flowering) the edited
lines had already reached the total sapogenin “threshold,” so the
corresponding genes did not appear induced with respect to the
control line. The hypothesis of a “threshold” value for sapogenin
content is reinforced considering the role of CYP88A13, the
gene responsible for the conversion of medicagenic to zanhic
acid, highly induced in leaves of the CYP93E2 mutant lines. The
conversion of medicagenic to zanhic acid could act as a leaf-
specific way to maintain medicagenic acid within a genetically
determined range. In fact, zanhic acid saponins showed lower
hemolytic activities compared with medicagenic acid saponins
(Oleszek et al., 1992), resulting in a reduced ability to cause
membrane perturbation. The mutant lines showed higher levels
of hemolytic sapogenins and in particular of medicagenic acid
compared to the control line so the induction of CYP88A13 can
be part of this balance mechanism. Evidence of this mechanism
was found in leaves of Medicago inter-specific hybrid derivatives
(Carelli et al., 2015), where no correlation between zanhic
acid and the other hemolytic sapogenin content was found,
but a strict control of medicagenic/zanhic ratio was evidenced.
Differently from leaves and stems, roots were characterized by
a larger number of aglycones; among these, the precursors of
medicagenic acid (Figure 1; Tables 1, 2) in the control line
represented 57% of the total hemolytic sapogenins with respect
to 1% in leaves. The edited lines compensated the absence
of root soyasapogenols by increasing, though not significantly,
all the classes of hemolytic sapogenins by the intervention
of CYP716A12 (oleanolic acid), CYP716A12 and CYP72A67
(2β-hydroxy oleanolic acid), CYP716A12 and CYP72A68-
mediated hydroxylation (hederagenin), CYP716A12, CYP72A67
and CYP72A68-mediated carboxylation (medicagenic acid)
(Figure 1). Then, the absence of a prevailing hemolytic sapogenin
biosynthetic target in root, as it is the case for medicagenic
acid in leaves, lead to a more diversified expression pattern of
the sapogenin biosynthetic genes in the edited lines that could
account for the lack of significant differences from the control.
With regard to CRISPR/Cas9 mediated gene editing of
CYP72A61, it was not possible to recover somatic embryos and
regenerate transformed plantlets carrying mutations in the target
sequences. In fact, when leaf explants with calli were transferred
to a selective hormone-free medium, somatic embryos started to
develop, but only in the control, pointing to an effect dependent
on the role of the targeted gene. P450s are involved in the
synthesis of secondary metabolites and are known for their
roles in many important cell processes. In particular, they are
involved in the regulation of plant hormone metabolism and
they function directly in plant growth and development (Xu
et al., 2015). The manipulation of the biosynthesis of saponins
and their intermediates which accumulate during normal
growth and development can determine morphological and
physiological effects at various developmental stages, including
seed germination, vegetative growth, flowering and embryo
development, fruiting and nodulation, suggesting additional
roles for these molecules in primary plant processes (Moses
et al., 2014a). As far as we know, the only manuscript
describing the effects of alteration of endogenous levels of
triterpenes on embryogenesis was published by Go et al. (2012).
In particular, knock-out Arabidopsis mutants for marneral
synthase 1 (MRN1), which converts 2,3-oxidosqualene to the
triterpene marneral, displayed altered levels of triterpenoids
and sterols, delayed zygotic embryogenesis, reduced growth
and late flowering (Go et al., 2012). It is possible that
the mutation in CYP72A61 is responsible for the absence
of somatic embryo differentiation under selective in vitro
conditions, presumably resulting from the altered flux balances
among hormone and/or saponin biosynthesis, suggesting that
CYP72A61 might be involved in inhibition of embryo and
shoot development and therefore important for plant growth
and survival. Also, mutations of genes encoding P450s involved
in saponin biosynthesis have revealed negative effects on plant
growth processes that may be related to the accumulation of toxic
intermediated (Moses et al., 2014a). CYP72A61 in M. truncatula
catalyzes the hydroxylation of C-22 in 24-hydroxy-β-amyrin
(the product of CYP93E2) to yield soyasapogenol B (Fukushima
et al., 2013). A loss of function mutation in CYP72A61
could presumably determine accumulation of 24-hydroxy-β-
amyrin. This metabolic intermediate of soyasapogenols does not
normally accumulate in the plant, and could result in toxic
effects on somatic embryogenesis. To address both hypotheses,
comprehensive molecular and metabolomic studies will be
required to confirm the CYP72A61 mutations by CRISPR/Cas9
system and their effects at the cellular level, and the presence of
24-hydroxy-β-amyrin in undifferentiated calli.
In conclusion, we have assessed the in planta role of CYP93E2
in triterpene saponin biosynthesis in M. truncatula. The present
Frontiers in Plant Science | www.frontiersin.org 13 July 2021 | Volume 12 | Article 690231
Confalonieri et al. Sapogenin Modulation by Genome Editing
study reports generation of CYP93E2 barrel medic mutants
with high efficiency by CRISPR/Cas9-mediated mutagenesis, and
demonstrates for the first time the success of this strategy to block
the metabolic flux toward non-hemolytic saponins, highlighting
the potential for converting β-amyrin to valuable hemolytic
saponins. These mutant plants with high content of hemolytic
saponins are consistent with the potential industrial extraction of
saponins for a wide range of applications. Our findings provide
new and interesting insights into the application of CRISPR/Cas9
for metabolic engineering of high-value compounds of plant
origin, offer the opportunity to develop new biological sources
and additional useful informations to further investigate the
physiological functions of saponins in planta.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/Supplementary Material, further inquiries can be
directed to the corresponding author/s.
AUTHOR CONTRIBUTIONS
MCo: conceived and planned the study, designed and
performed genetic transformation, tissue culture and growth
chamber/greenhouse experiments, analyzed the data, and wrote
the manuscript. SG and AM: designed and cloned gene editing
constructs and contributed to the revision of the manuscript.
MCa: conducted PCR and QRT-PCR experiments, analyzed the
data, and contributed to the revision of the manuscript. EB and
AT: performed biochemical analyses. All authors contributed to
the article and approved the submitted version.
FUNDING
Research was financially supported by ROP ERDF 2014-2020
Lombardy – Innovation e Competitiveness.
ACKNOWLEDGMENTS
We thank Dr. Carla Scotti from CREA-ZA, Lodi for her valuable
revision of the manuscript. We are also grateful to Barbara
Pintus for technical assistance and Prof. Manuel Pedro Salema
Fevereiro from ITQB, Oeiras (Portugal) for providing the M9-
10aMedicago truncatula genotype.
SUPPLEMENTARY MATERIAL




Aliaga-Franco, N., Zhang, C., Presa, S., Srivastava, A. K., Granell, A., Alabadí,
D., et al. (2019). Identification of transgene-free CRISPR-edited plants of rice,
tomato, andArabidopsis bymonitoring DsRED fluorescence in dry seeds. Front
Plant Sci. 18:1150. doi: 10.3389/fpls.2019.01150
Argentieri, M. P., DAddabbo, T., Tava, A., Agostinelli, A., Jurzysta, M., and Avato,
P. (2008). Evaluation of nematicidal properties of saponins fromMedicago spp.
Eur. J. Plant Pathol. 120, 189–197. doi: 10.1007/s10658-007-9207-8
Augustin, J. M., Kuzina, V., Andersen, S. B., and Bak, S. (2011). Molecular
activities, biosynthesis and evolution of triterpenoid saponins. Phytochem. 72,
435–457. doi: 10.1016/j.phytochem.2011.01.015
Avato, P., Bucci, R., Tava, A., Vitali, C., Rosato, A., Bialy, Z., et al. (2006).
Antimicrobial activity of saponins from Medicago spp.: structure–activity
relationship. Phytother. Res. 20, 454–457. doi: 10.1002/ptr.1876
Avato, P., Migoni, D., Argentieri, M., Fanizzi, F. P., and Tava, A. (2017). Activity
of saponins from Medicago species against HeLa and MCF-7 cell lines and
their capacity to potentiate cisplatin effect. Anticancer Agents Med. Chem. 17,
1508–1518. doi: 10.2174/1871520617666170727152805
Balestrazzi, A., Agoni, V., Tava, A., Avato, P., Biazzi, E., Raimondi, E., et al.
(2011). Cell death induction and nitric oxide biosynthesis in white poplar
(Populus alba) suspension cultures exposed to alfalfa saponins. Physiol. Plant.
141, 227–238. doi: 10.1111/j.1399-3054.2010.01436.x
Biazzi, E., Carelli, M., Tava, A., Abbruscato, P., Losini, I., Avato, P., et al. (2015).
CYP72A67 catalyzes a key oxidative step in Medicago truncatula hemolytic
saponin biosynthesis.Mol. Plant 8, 1493–1506. doi: 10.1016/j.molp.2015.06.003
Bora, K. S., and Sharma, A. (2011). Phytochemical and pharmacological
potential of Medicago sativa: a review. Pharm. Biol. 49, 211–220.
doi: 10.3109/13880209.2010.504732
Brinkman, E. K., Chen, T., Amendola, M., and van Steensel, B. (2014). Easy
quantitative assessment of genome editing by sequence trace decomposition.
Nucleic Acids Res. 42:e168. doi: 10.1093/nar/gku936
Carelli, M., Biazzi, E., Panara, F., Tava, A., Scaramelli, L., Porceddu, A.,
et al. (2011). Medicago truncatula CYP716A12 is a multifunctional oxidase
involved in the biosynthesis of hemolytic saponins. Plant Cell 23, 3070–3081.
doi: 10.1105/tpc.111.087312
Carelli, M., Biazzi, E., Tava, A., Losini, I., Abbruscato, P., Depedro, C., et al. (2015).
Sapogenin content variation in Medicago inter-specific hybrid derivatives
highlights some aspects of saponin synthesis and control. New Phytol. 206,
303–314. doi: 10.1111/nph.13162
Carelli, M., Confalonieri, M., Tava, A., Biazzi, E., Calderini, O., Abbruscato, P., et al.
(2020). “Saponin synthesis in Medicago truncatula plants: CYP450-mediated
formation of sapogenins in the different plant organs,” in The Model Legume
Medicago truncatula, eds F. J. de Bruijn (Bridgewater, NJ: John Wiley & Sons,
Inc.), 225–236.
Confalonieri, M., Cammareri, M., Biazzi, E., Pecchia, P., Fevereiro, M. P.,
Balestrazzi, A., et al. (2009). Enhanced triterpene saponin biosynthesis and
root nodulation in transgenic barrel medic (Medicago truncatula Gaertn.)
expressing a novel beta-amyrin synthase (AsOXA1) gene. Plant Biotechnol J.
7, 172–182. doi: 10.1111/j.1467-7652.2008.00385.x
Confalonieri, M., and Sparvoli, F. (2020). “Recent advances in Medicago spp.
genetic engineering strategies,” in The Model Legume Medicago truncatula, ed.
F. J. de Bruijn (Bridgewater, NJ: John Wiley & Sons, Inc.), 1149–1161.
Curtin, S. J., Tiffin, P., Guhlin, J., Trujillo, D. I., Burghardt, L. T., Atkins, P., et al.
(2017). Validating genome-wide association candidates controlling quantitative
variation in nodulation. Plant Physiol. 173, 921–931. doi: 10.1104/pp.16.01923
Curtin, S. J., Xiong, Y., Michno, J. M., Campbell, B. W., Stec, A. O., Cermák, T.,
et al. (2018). CRISPR/Cas9 and TALENs generate heritable mutations for genes
involved in small RNA processing of Glycine max and Medicago truncatula.
Plant Biotechnol. J. 16, 1125–1137. doi: 10.1111/pbi.12857
da Silva Magedans, Y. Y., Phillips, M. A., and Fett-Neto, A. G. (2020). Production
of plant bioactive triterpenoid saponins: from metabolites to gene and back.
Phytochem. Rev. 20, 461–482. doi: 10.1007/s11101-020-09722-4
D’Addabbo, T., Argentieri, M. P., Zuchowski, J., Biazzi, E., Tava, A., Oleszek, W.
et al. (2020). Activity of saponins fromMedicago species against phytoparasitic
nematodes. Plants 9:443. doi: 10.3390/plants9040443
Do, P. T., Nguyen, C. X., Bui, H. T., Tran, L. T. N., Stacey, G., Gillman, J. D., et al.
(2019). Demonstration of highly efficient dual gRNA CRISPR/Cas9 editing of
Frontiers in Plant Science | www.frontiersin.org 14 July 2021 | Volume 12 | Article 690231
Confalonieri et al. Sapogenin Modulation by Genome Editing
the homeologous GmFAD2–1A and GmFAD2–1B genes to yield a high oleic,
low linoleic and α-linolenic acid phenotype in soybean. BMC Plant Biol. 19:311.
doi: 10.1186/s12870-019-1906-8
Doudna, J. A., and Charpentier, E. (2014). The new frontier of genome engineering
with CRISPR-Cas9. Science 346:1258096. doi: 10.1126/science.1258096
Ellen, D., Ellen, L., Danny, G., and Guy, S. (2007). Novel advances with plant
saponins as natural insecticides to control pest insects. Pest Tech. 1, 96–105.
Faè, M., Balestrazzi, A., Confalonieri, M., Donà, M., Macovei, A., Valassi,
A., et al. (2014). Copper-mediated genotoxic stress is attenuated by
the overexpression of the DNA repair gene MtTdp2α (tyrosyl-DNA
phosphodiesterase 2) in Medicago truncatula plants. Plant Cell Rep. 33,
1071–1080. doi: 10.1007/s00299-014-1595-6
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., et al. (2013).
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in
human cells. Nat. Biotechnol. 31, 822–826. doi: 10.1038/nbt.2623
Fukushima, E. O., Seki, H., Ohyama, K., Ono, E., Umemoto, N., Mizutani,
M., et al. (2011). CYP716A subfamily members are multifunctional
oxidases in triterpenoid biosynthesis. Plant Cell Physiol. 52, 2050–2061.
doi: 10.1093/pcp/pcr146
Fukushima, E. O., Seki, H., Sawai, S., Suzuki, M., Ohyama, K., Saito, K., et al.
(2013). Combinatorial biosynthesis of legume natural and rare triterpenoids in
engineered yeast. Plant Cell Physiol. 54, 740–749. doi: 10.1093/pcp/pct015
Gao, R., Feyissa, B. A., Croft, M., and Hannoufa, A. (2018). Gene editing
by CRISPR/Cas9 in the obligatory outcrossing Medicago sativa. Planta 247,
1043–1050. doi: 10.1007/s00425-018-2866-1
Go, Y. S., Lee, S. B., Kim, H. J., Kim, J., Park, H. Y., Kim, J. K.,
et al. (2012). Identification of marneral synthase, which is critical
for growth and development in Arabidopsis. Plant J. 72, 791–804.
doi: 10.1111/j.1365-313X.2012.05120.x
Hahn, F., and Nekrasov, V. (2019). CRISPR/Cas precision: do we need
to worry about off-targeting in plants? Plant Cell Rep. 38, 437–441.
doi: 10.1007/s00299-018-2355-9
Haralampidisis, K., Trojanowska, M., and Osbourn, A. (2002). “Biosynthesis
of triterpenoid saponins in plants,” in Advances in Biochemical
Engineering/Biotechnology, ed T. Scheper (Berlin Heidelberg: Springer), 31–49.
Kapusta, I., Bogdan, J., Stochmal, A., and Oleszek, W. (2005). Determination
of saponins in aerial parts of barrel medic (Medicago truncatula) by liquid
chromatography-electrospray ionization/mass spectrometry. J. Agric. Food
Chem. 53, 7654–7660. doi: 10.1021/jf051256x
Krishnamurthy, P., Fujisawa, Y., Takahashi, Y., Abe, H., Yamane, K., Mukaiyama,
K., et al. (2019). High throughput screening and characterization
of a high-density soybean mutant library elucidate the biosynthesis
pathway of triterpenoid saponins. Plant Cell Physiol. 60, 1082–1097.
doi: 10.1093/pcp/pcz025
Lambert, E., Faizal, A., and Geelen, D. (2011). Modulation of triterpene saponin
production: in vitro cultures, elicitation, and metabolic engineering. Appl.
Biochem. Biotechnol. 164, 220–237. doi: 10.1007/s12010-010-9129-3
Lei, Z., Watson, B. S., Huhman, D., Yang, D. S., and Sumner, L. W. (2019). Large-
scale profiling of saponins in different ecotypes of Medicago truncatula. Front.
Plant Sci. 10:850. doi: 10.3389/fpls.2019.00850
Li, X., Wang, Y., Chen, S., Tian, H., Fu, D., Zhu, B., et al. (2018). Lycopene is
enriched in tomato fruit by CRISPR/Cas9-mediated multiplex genome editing.
Front Plant Sci. 9:559. doi: 10.3389/fpls.2018.00559
Liu, Y., Merrick, P., Zhang, Z., Ji, C., Yang, B., and Fei, S. Z. (2018).
Targeted mutagenesis in tetraploid switchgrass (Panicum virgatum L.) using
CRISPR/Cas9. Plant Biotechnol. J. 16, 381–393. doi: 10.1111/pbi.12778
Ma, X., Zhang, Q., Zhu, Q., Liu, W., Chen, Y., Qiu, R., et al. (2015).
A robust CRISPR/Cas9 system for convenient, high-efficiency multiplex
genome editing in monocot and dicot plants. Mol. Plant 8, 1274–1284.
doi: 10.1016/j.molp.2015.04.007
Maestrini, M., Tava, A., Mancini, S., Salari, F., and Perrucci, S. (2019). In vitro
anthelmintic activity of saponins derived from Medicago spp. plants against
donkey gastrointestinal nematodes. Vet. Sci. 6:35. doi: 10.3390/vetsci6020035
Maestrini, M., Tava, A., Mancini, S., Tedesco, D., and Perrucci, S. (2020). In
vitro anthelmintic activity of saponins from Medicago spp. against sheep
gastrointestinal nematodes.Molecules 25:242. doi: 10.3390/molecules25020242
Maioli, A., Gianoglio, S., Moglia, A., Acquadro, A., Valentino, D., Milani, A. M.,
et al. (2020). Simultaneous CRISPR/Cas9 editing of three PPO genes reduces
fruit flesh browning in Solanum melongena L. Front. Plant Sci. 11:607161.
doi: 10.3389/fpls.2020.607161
Manghwar, H., Lindsey, K., Zhang, X., and Jin, S. (2019). CRISPR/Cas system:
recent advances and future prospects for genome editing. Trend Plant Sci. 24,
1102–1125. doi: 10.1016/j.tplants.2019.09.006
Meng, Y., Hou, Y., Wang, H., Ji, R., Liu, B., Wen, J., et al. (2017).
Targeted mutagenesis by CRISPR/Cas9 system in the model legume Medicago
truncatula. Plant Cell Rep. 36, 371–374. doi: 10.1007/s00299-016-2069-9
Michno, J. M., Wang, X., Liu, J., Curtin, S. J., Kono, T. J. Y., and Stupar, R. M.
(2015). CRISPR/Cas mutagenesis of soybean and Medicago truncatula using
a new web-tool and a modified Cas9 enzyme. GM Crops Food 6, 243–252.
doi: 10.1080/21645698.2015.1106063
Moses, T., Papadopoulou, K. K., and Osbourn, A. (2014a). Metabolic
and functional diversity of saponins, biosynthetic intermediates and
semi-synthetic derivatives. Crit. Rev. Biochem. Mol. Biol. 49, 439–462
doi: 10.3109/10409238.2014.953628
Moses, T., Thevelein, J. M., Goossens, A., and Pollier, J. (2014b). Comparative
analysis of CYP93E proteins for improved microbial synthesis of plant
triterpenoids. Phytochem. 108, 47–56. doi: 10.1016/j.phytochem.2014.10.002
Naoumkina, M. A., Modolo, L. V., Huhman, D. V., UrbanczykWochniak, E.,
Tang, Y., Sumner, L. W., et al. (2010). Genomic and coexpression analyses
predict multiple genes involved in triterpene saponin biosynthesis inMedicago
truncatula. Plant Cell 22, 850–866. doi: 10.1105/tpc.109.073270
Neves, L. O. (2000). Regeneration and Transformation of Barrel Medic (Medicago
truncatula Gaertn. cv. Jemalong) (PhD dissertation thesis). Faculdade de
Ciências da Universidade de Lisboa, Lisboa.
Nian, C. S., Neelakandan Anjanasree, K., Nahampun, H., Bronwyn, F., Main, M.,
Spalding Martin, H., et al. (2017). An Agrobacterium-delivered CRISPR/Cas9
system for high-frequency targeted mutagenesis in maize. Plant Biotechnol J.
15, 257–268. doi: 10.1111/pbi.12611
Oleszek, W., Jurzysta, M., Ploszynski, M., Colquhoun, I. J., Price, K. R., and
Fenwick, G. R. (1992). Zahnic acid tridesmoside and other dominant saponins
from alfalfa (Medicago sativa) aerial parts. J. Agric. Food Chem. 40, 191–196.
doi: 10.1021/jf00014a005
Pateraki, I., Heskes, A. M., and Hamberger, B. (2015). Cytochromes P450 for
terpene functionalisation and metabolic engineering. Adv. Biochem. Eng.
Biotechnol. 148, 107–139. doi: 10.1007/10_2014_301
Pauwels, L., De Clercq, R., Goossens, J., Iñigo, S., Williams, C., Ron, M., et al.
(2018). A dual sgRNA approach for functional genomics in Arabidopsis
thaliana. G3 Genes Genomes Genet. 8, 2603–2615. doi: 10.1534/g3.118.200046
Pay, A., Heberle-Bors, E., and Hirt, H. (1992). An alfalfa cDNA encodes a protein
with homology to translationally controlled human tumor protein. Plant Mol.
Biol. 19, 501–503. doi: 10.1007/BF00023399
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